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Gram-negative bacteria ubiquitously produce and release nano-size, non-replicative
outer membrane vesicles (OMVs). In the gastrointestinal (GI-) tract, OMVs generated
by members of the intestinal microbiota are believed to contribute to maintaining
the intestinal microbial ecosystem and mediating bacteria–host interactions, including
the delivery of bacterial effector molecules to host cells to modulate their physiology.
Bacterial OMVs have also been found in the bloodstream although their origin and fate
are unclear. Here we have investigated the interactions between OMVs produced by
the major human gut commensal bacterium, Bacteroides thetaiotaomicron (Bt), with
cells of the GI-tract. Using a combination of in vitro culture systems including intestinal
epithelial organoids and in vivo imaging we show that intestinal epithelial cells principally
acquire Bt OMVs via dynamin-dependent endocytosis followed by intracellular trafficking
to LAMP-1 expressing endo-lysosomal vesicles and co-localization with the perinuclear
membrane. We observed that Bt OMVs can also transmigrate through epithelial cells
via a paracellular route with in vivo imaging demonstrating that within hours of oral
administration Bt OMVs can be detected in systemic tissues and in particular, the
liver. Our findings raise the intriguing possibility that OMVs may act as a long-distance
microbiota–host communication system.
Keywords: Bacteroides thetaiotaomicron, outer membrane vesicles, microvesicles, bacterial extracellular
vesicles, gut microbiota, GI-tract, biodistribution, organoid monolayer
Abbreviations: BHI, brain heart infusion; Bt, Bacteroides thetaiotaomicron; DiD, 1,1′-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate; DiO, 3,3-dioctadecyloxacarbocyanine perchlorate; ER, endoplasmic reticulum;
EV, extracellular vesicle; FITC, fluorescein isothiocyanate; GCDR, gentle cell dissociation reagent; GI, gastrointestinal;
HO, Home Office; IEC, intestinal epithelial cell; OmpA, outer membrane protein-A; OMV, outer membrane vesicle; PFA,
paraformaldehyde; SI, small intestine; TBS, tris buffered saline; TEER, transepithelial electrical resistance; TEM, transmission
electron microscope; TJ, tight junction.
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INTRODUCTION
The mammalian GI-tract is home to a vast number of microbes
that make up the intestinal microbiota which has co-evolved
with the host to establish a mutualistic relationship (Round and
Mazmanian, 2009). Complex interactions between the intestinal
microbiota and the host intestinal epithelium and underlying
immune cells play a vital role in maintaining GI homeostasis, host
health, and preventing infection (Sommer and Backhed, 2013).
Although the mucus layer that coats the entirety of the intestinal
epithelium prevents direct contact of luminal microbes with host
cells, bacterial products such as metabolites or bacterial OMVs,
can access and cross the epithelial barrier (Fateh et al., 2015)
to influence both local and systemic host responses (Bomberger
et al., 2009; Stentz et al., 2014).
Gram-negative bacteria ubiquitously shed bilayer OMVs into
their external environment (Brown et al., 2015; Schwechheimer
and Kuehn, 2015). These non-replicative spherical vesicles bud
from the bacterial outer membrane and range in size from 20 to
400 nm (Toyofuku et al., 2019). The protective outer lipid bilayer
encapsulates and protects their cargo of bioactive proteins,
nucleic acids, and metabolites (Bryant et al., 2017). OMVs are
increasingly being recognized as a key mode of interkingdom
communication between bacteria and host tissues, contributing
to a diverse range of functions including nutrient uptake,
gene transfer, biofilm formation, antimicrobial protection, and
transfer of microbial toxins and virulence factors during infection
(Kulp and Kuehn, 2010; Jan, 2017). However, the molecular
basis and pathways of host-OMV uptake and the fate of host-
cell acquired OMVs and their cargo remain elusive (Margolis
and Sadovsky, 2019). Bacterial OMVs have been shown to
interact with many different mammalian cell types including
IECs (Parker et al., 2010; Bielaszewska et al., 2013; Stentz et al.,
2014; O’Donoghue et al., 2017), lung epithelial cells (Bauman and
Kuehn, 2009), endothelial cells (Kim et al., 2013), and immune
cells (Vidakovics et al., 2010; Yoon et al., 2011; Hickey et al., 2015;
Vanaja et al., 2016; Deo et al., 2018). Bacterial DNA of potential
OMV origin has also been detected in human blood and urine
(Yoo et al., 2016; Lee et al., 2017; Park et al., 2017) as well as
in body compartments previously thought to be sterile, such as
the heart (Svennerholm et al., 2017), suggesting OMVs can reach
distant sites from their site of origin and production, including
the lumen of the GI-tract (Stentz et al., 2018).
Historically, studies of OMVs have focused on those
produced by pathogenic Gram-negative bacteria and their role
in transporting virulence factors and toxins into host cells
(Kunsmann et al., 2015; Bielaszewska et al., 2017; Deo et al.,
2018; Rasti et al., 2018). Recently, studies have emerged showing
OMVs released by commensal and probiotic bacteria may confer
beneficial effects on the host by maintaining microbial and GI-
tract homeostasis by influencing host epithelial and immune cell
responses. For example, we have shown that OMVs generated
by the major human commensal gut bacterium Bt can activate
host immune responses when delivered intranasally and via the
GI-tract (Carvalho et al., 2019). Probiotic Escherichia coli strain
Nissle 1917 OMVs have been shown to aid in maintaining the
gut barrier by upregulating expression of barrier enhancing TJ
proteins zonula occludens-1 and claudin-14 (Alvarez et al., 2016),
and by enhancing production of antimicrobial proteins and anti-
inflammatory cytokines (Fabrega et al., 2016, 2017; Alvarez et al.,
2019). Similarly, OMVs generated by Bacteroides fragilis have
been shown to elicit immunomodulatory effects and prevent gut
inflammation in a mouse model of colitis (Shen et al., 2012).
Although these findings highlight the ability of OMVs to
influence host cell physiology, we still do not fully understand
the diverse mechanisms of OMV uptake and cargo delivery. The
study of OMV uptake is challenging due to their nano-size and
the fact that the molecular mechanisms OMVs might use to drive
microbiota–host interactions are poorly understood compared
to studies of pathogenic bacteria (Stentz et al., 2018). Several
OMV internalization pathways have been identified for certain
bacterial species including actin-dependent macropinocytosis,
clathrin-mediated endocytosis, caveolin-mediated endocytosis,
or clathrin- and caveolin-independent mechanisms such as
membrane fusion or lipid raft formation (O’Donoghue and
Krachler, 2016). However, uptake of OMVs generated by
commensal microbiota species such as Bacteroides spp. have not
been studied in detail. The aim of the present study therefore
was to evaluate Bt OMV uptake and trafficking pathways within
host cells and track their biodistribution using the strain VPI-
5482. This strain is widely used as a model commensal bacterium
for investigating host–bacteria interactions (Hooper et al., 2003;
Eckburg et al., 2005; Rakoff-Nahoum et al., 2014; Stentz et al.,
2014, 2015; Zakharzhevskaya et al., 2017). Using a combination
of in vitro and in vivo imaging techniques we have shown that
commensal Bt OMVs are internalized by IECs via several routes
including dynamin-dependent endocytosis, macropinocytosis,
and caveolin-mediated endocytosis and are ultimately sorted
to a peri-nuclear localization through host–cell endo-lysosomal
pathways. We also demonstrate that a proportion of Bt OMVs
localize to cellular junctions whereby they can cross the intestinal
epithelium by paracellular transmigration to disseminate widely
throughout the host.
MATERIALS AND METHODS
Animal Handling
Eight- to twelve-week-old C57BL/6 and Atg16l1IEC (Jones et al.,
2019) single sex mice were bred and maintained in the University
of East Anglia (United Kingdom) animal facility. All mice
were housed in individually ventilated cages and exposed to a
12 h light/dark cycle with free access to water and a standard
laboratory chow diet. Animal experiments were conducted in full
accordance with the Animal Scientific Procedures Act 1986 under
UK HO approval and HO project license 70/8232.
Mammalian Cell Culture
The human colonic epithelial cell line Caco-2 (ECACC 86010202)
was cultured at 37◦C and 5% CO2 in Dulbecco’s Modified
Eagle Medium with 4.5 g/L glucose and 2 mM L-glutamine
(Sigma) supplemented with 5% fetal bovine serum (Lonza), 1%
non-essential amino acids (Sigma), penicillin (100 U/ml), and
streptomycin (100 µg/ml) (Sigma).
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Intestinal Organoid Monolayer Culture
Small intestinal or caecal crypts were isolated from mouse
tissue using a modified method of Jones et al. (2019). Briefly,
the GI-tract tissues were opened longitudinally, washed in ice-
cold DPBS then cut into 5-mm pieces. The tissue fragments
were incubated in GCDR (StemCell Technologies) for 15 min
then transferred to ice-cold DPBS for shaking, then returned
to GCDR for 5 min. This process was repeated until three to
five fractions were generated and then inspected for released
crypts. The crypt suspensions were passed through a 70-µm
filter to remove debris, then centrifuged at 300 × g for 5 min.
Crypt pellets were resuspended in murine organoid growth
media (StemCell Technologies) supplemented with 10 µg/ml
rho-associated coiled-coil containing protein kinase inhibitor
(Y-27632, TOCRIS) and seeded onto culture ware coated with
Cultrex reduced growth factor basement membrane matrix, type
2 (R&D Systems) at a density of 1000 crypts/ml.
Bacterial Strains and OMV Isolation
Bt VPI-5482 was grown under anaerobic conditions at 37◦C
in BHI medium (Oxoid) supplemented with 15 µM hemin
or with 0.75 µM hemin for OMV preparations. Bt OMVs
were isolated and purified following a method adapted from
Stentz et al. (2014). Briefly, cultures (500 mL) of Bt were
centrifuged at 5500 × g for 45 min at 4◦C and the supernatants
filtered through 0.22-µm pore-size polyethersulfone membranes
(Sartorius) to remove debris and cells. The supernatants were
concentrated by crossflow ultrafiltration (100 kDa MWCO,
Vivaflow 50R, Sartorius) and the retentate rinsed once with
500 mL of PBS (pH 7.4). The OMV suspensions were
concentrated to 1 ml in sterile PBS, filtered through 0.22 µm
pore-size syringe-filters (Sartorius), and stored at 4◦C. The
sterility of the OMV suspension was confirmed by plating onto
BHI–hemin agar. The size and concentration of Bt OMVs
was determined using a Nanosight nanoparticle instrument
(Malvern Instruments). A 1-min AVI file was recorded and
analyzed using nanoparticle tracking analysis (Version 2.3 Build
0011 RC, Nanosight) software to calculate size distributions
and vesicle concentrations, expressed as particle size (nm)
versus number of particles per milliliter. The settings were as
follows: calibration: 166 nm/pixel; blur: auto; detection threshold:
10, minimum track length: auto, temperature: 21.9◦C, and
viscosity: 0.96 cP.
Fluorescence Microscopy
Bt OMVs (1 × 1011/mL) were labeled with 5% (v/v) DiO
or DiD Vybrant cell-labeling solution (Molecular probes) by
incubating at 37◦C for 30 min. Unbound dye was removed by
washing with 3× PBS using centrifugal filters (100 kDa MWCO,
Sartorius). Labeled OMVs (1 × 1010/mL) were added to Caco-2
monolayers cultured on collagen solution (Sigma) coated 24-well
chamber slides (IBIDI) or primary mouse organoid monolayers
cultured on BME2-coated slides for up to 48 h. This OMV
concentration was determined to represent optimal fluorescence
signal for microscopy imaging (data not shown). Samples were
fixed using Pierce 4% PFA (ThermoFisher), permeabilized with
0.25% Triton X100 (Sigma), and blocked with 10% goat serum
in PBS. Intracellular membranes were visualized using Alexa
647-Phalloidin, anti-PDI for ER, anti-58k for Golgi network,
anti-Tomm20 for mitochondria, anti-Lamin B1 for nuclear
membrane, anti-Rab5 for early endosomes, anti-LAMP1 for
lysosomes, and anti-E-cadherin for lateral cell membranes. All
secondary antibodies were Alexa 594-conjugated goat anti-rabbit
or anti-mouse unless otherwise stated. Antibodies were prepared
using TBS (50 mM) (pH 7.6; Sigma) as diluent containing 1%
bovine serum albumin (Sigma). For nuclear visualization, cells
were incubated with Hoechst 33342 (ThermoFisher). TBS was
used as a wash buffer throughout (unless otherwise stated) and
all incubations were carried out at ambient temperature. Cells
were mounted with high precision glass slides (IBIDI) using
Fluoromount-G antifade mounting medium (SouthernBiotech).
Images were taken using a Zeiss Axioimager.M2 microscope,
equipped with a Plan-Apochromat 63×/1.4 oil immersion
objective and ZEN blue software. Fluorescence was recorded
at 405 (blue, nucleus), 488 (green, OMVs), and 594 nm (red,
Alexa-594 immunostaining). Uptake of DiO-OMVs by Caco-
2 was quantified using sum fluorescent pixel intensity of the
field of view using a macro written in Image J/FIJI v1.52p.
The arbitrary fluorescence units were normalized to PBS control
and the mean of each group expressed as average fluorescence
intensity (AU). For pH-dependent staining of lysosomes, Caco-
2 were cultured on collagen-coated glass coverslips in a 24-
well plate prior to treatment with Bt OMVs as above and
staining with LysoID red detection kit (ENZO) according to
manufacturer’s instructions. Images were taken as above with
an EC Plan-Neofluar 20×/0.50 objective. All image analysis
was performed using Image J/FIJI v1.52p. Yellow coloration
in merged image panels indicates co-localization of Alexa-
594 immunostaining with DiO-OMVs. Co-localization analysis
of pixel intensity was quantified using the Coloc2 plugin in
Image J/FIJI v1.52p and represented in the text as Pearson’s
correlation coefficient (r). In addition, a Zeiss LSM880 Airyscan
confocal microscope equipped with a 63×/1.4 Oil DIC objective
and ZEN black software (ZEISS) was used to obtain higher
resolution images with Z-stack images (6.4–7.6 µm) at 0.38–
0.4 µm per slice.
Live Imaging Using Confocal
Fluorescence Microscopy
Caco-2 monolayers were cultured on collagen (Sigma) coated
35 mm glass bottom µ-dishes (IBIDI) and stained with
CellTracker red CMTPX dye (ThermoFisher) according to
manufacturer’s instructions. Briefly, cells were incubated with
5 µM CellTracker red CMTPX dye for 15 min followed by
repeated washes with cell media. Cells were treated with DiO-
labeled Bt OMVs (1 × 1010/mL) and live imaging immediately
performed using a Zeiss LSM880 Airyscan confocal microscope
equipped with a W N-Achroplan 63×/0.9 dipping objective.
Fluorescence was recorded at 405 (blue, nucleus), 488 (green,
OMVs), and 602 nm (red, CellTracker). Z-stacks at 0.9 µm
per slice were acquired using ZEN Black software (ZEISS). All
image analysis was performed using Image J/FIJI v1.52p. Yellow
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coloration in merged image panels indicates co-localization of
CellTracker with DiO-OMVs.
Electron Microscopy
Bt OMVs were observed using negative staining with
transmission electron microscopy (TEM) as previously described
(Stentz et al., 2015). Briefly, isolated Bt OMVs were adsorbed to
carbon–formvar-coated copper EM grids (Agar Scientific) for
1 min before wicking off with filter paper and negatively staining
with 2% uranyl acetate solution (BDH) in water for 1 min. Grids
were air-dried before analysis using a Tecnai G2 20 Twin TEM
(FEI) at 29,000×magnification.
Endocytosis Assay
Caco-2 monolayers were pre-treated with inhibitors of
endocytosis: Dynasore (80 µM; clathrin- and caveolin-
mediated endocytosis inhibitor), cytochalasin D (1 µg/mL;
macropinocytosis membrane fusion inhibitor), chlorpromazine
(15 µg/mL; clathrin-dependent endocytosis inhibitor), nystatin
(50 µM; caveolin-mediated endocytosis and lipid raft inhibitor),
or amiloride (10 mM; macropinocytosis inhibitor) (all Sigma)
for 1 h at 37◦C and 5% CO2 with gentle rocking prior to
treatment with Bt OMVs (1 × 1010/mL) or PBS control for
6 h. Samples were washed with 3 × PBS and extracellular DiO
fluorescence quenched using 0.025% trypan blue (Sigma) prior
to fixing with Pierce 4% PFA (ThermoFisher) for 20 min. OMV
uptake was quantified by fluorescence microscopy using a Zeiss
Axioimager.M2 equipped with an EC Plan-Neofluar 40×/0.75
objective and ZEN blue software. Fluorescence was recorded
at 488 nm (green, OMVs) and image analysis was performed
using Image J/FIJI v1.52p. Internalization of DiO-OMVs was
quantified using sum fluorescent pixel intensity of the field
of view using a macro written in Image J/FIJI v1.52p. The
mean arbitrary fluorescence units of each group were expressed
as % of control.
Transepithelial Electrical Resistance
Transepithelial electrical resistance measurements were
performed using a 24-well plate Transwell system (Greiner).
Caco-2 monolayers were seeded on the apical compartment of
0.4 µm transparent polyethylene terephthalate (PET) membrane
inserts until fully confluent. Bt OMVs (1 × 1010/mL) or PBS
control were added to the apical compartment and TEER
measurements recorded using an EVOM2 epithelial voltmeter
with chopstick electrode (World Precision Instruments Inc.).
FITC–Dextran Translocation
Using the Transwell system above, confluent Caco-2 monolayers
were treated with 1 mg/mL 3–5 kDa FITC–dextran (Sigma) in the
media of the apical compartment. Translocation of fluorescent
FITC–dextran into the basal media compartment was recorded
using a FLUOStar OPTIMA (BMG Labtech) at excitation 485 and
520 nm emission.
In vivo Biodistribution Imaging
Eight-week-old female C57BL/6 mice (n = 4/grp) were orally
administered DiD-labeled Bt OMVs at a dose of 2 × 1010
OMV/mouse or PBS (200 µL total volume/mouse). Organs
including heart, lungs, liver, kidney, spleen, and entire GI-tract
were excised at 8 h post administration and far-red fluorescence
acquired using an in vivo Xtreme multi-modal optical and
x-ray small animal imaging system (Bruker) equipped with a
back-illuminated 4MP CCD detector. Foreground far-red DiD
fluorescence was recorded with the following settings: excitation
650 nm and emission 700 nm, 19 cm field of view, 20 s
exposure time, fStop 1.1, and focal plane 0. Background image
was recorded by reflectance as above with an exposure time
of 1 s. Radiant efficiency of each organ was measured using
Bruker Molecular Imaging software (v 7.2.0.21148) by overlaying
foreground and background images and recording organs as
individual regions of interest (ROI). Data were displayed as
absolute fluorescence (photons/s/mm2) or normalized to PBS
control and calculating % fluorescence of all organs.
Statistical Analysis
All data are presented as the mean ± standard error of the mean
(SEM) with the indicated sample sizes. Data were subjected to
D’Agostino and Pearson omnibus normality test and p-values
calculated using Student’s unpaired t-test (fluorescence uptake
assay) one-way ANOVA followed by Dunnett’s (endocytosis
assay) or Bonferroni post hoc tests (OMV uptake assay, FITC–
dextran assay, and biodistribution assay) or two-way ANOVA
followed by Bonferroni post hoc test (TEER assay) using
GraphPad Prism 5 software (version 5.04). Statistically significant
differences between two mean values were considered when
∗p = 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001, and ∗∗∗∗p< 0.0001.
RESULTS
Characterization of Bt OMVs
Bt generated OMVs were isolated using ultracentrifugation and
filtration (Stentz et al., 2014). Electron microscopy imaging
showed that the isolated Bt OMV population comprised
of spherical, bilayered nano-sized vesicles of various sizes
(Figure 1A). Dynamic light scattering revealed Bt OMVs ranged
in size from 20 to 400 nm with a mean size of approximately
200 nm (Figure 1B). Furthermore, the majority (62.0%) were
routinely between 100 and 200 nm, with 40.8% between 200
and 400 nm, with 0.5% <100 nm, and with 0.46% >400 nm
(data not shown).
Bt OMV Uptake by Intestinal Epithelial
Cells
Using live cell imaging, it was observed that within 15 min of
exposure to Caco-2 cells Bt OMVs were associated with the
apical cell membrane with some already being internalized and
in close proximity to the nucleus (Figure 1C). To determine
the kinetics of OMV uptake, DiO-labeled Bt OMVs were
incubated with Caco-2 monolayers and intracellular fluorescence
intensity quantified at various timepoints over a 48 h period.
Fluorescence from extracellular OMVs was quenched using
trypan blue. A small proportion of Bt OMVs were internalized
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FIGURE 1 | Bt OMVs are rapidly acquired by intestinal epithelial cells. (A) Bt
generates OMVs of heterogeneous sizes when grown in nutrient-rich media as
shown by TEM. Scale bar = 200 nm. Images are representative of more than
three independent preparations. (B) Size distribution and concentration of Bt
OMVs using Nanosight NTA. Data are representative of more than three
independent preparations with the gray shading representing the extent of
variation of the different preparations. (C) Visualizing uptake of DiO-labeled Bt
OMVs by Caco-2 monolayers using live imaging and confocal microscopy.
Cell Tracker red CMTPX dye was used to visualize Caco-2 cells. The main
panel shows merged XY image with the bottom panel showing XZ orthogonal
view. Arrow heads indicate intracellular OMVs. The images shown are
representative of more than three independent experiments. (D) The uptake of
DiO-OMVs by Caco-2 monolayers increases over 48 h as determined by
quantification of DiO-OMVs using sum fluorescent pixel intensity of each field
of view using a macro written in Image J/FIJI v1.52p. The arbitrary
fluorescence units were normalized to PBS control samples and the mean of
each group expressed as average fluorescence intensity (AU). The graph
depicts mean ± SEM values from one independent experiment with ≥10
technical replicates.
after 30 min (1.4%), which increased over time up to 24 h
at which time a plateau of OMV uptake was evident (35.6%).
A significant proportion of OMVs were still visible 48 h
after administration (39.4%) (Figure 1D and Supplementary
Figure S3) which was not statistically different from the 24 h
timepoint (p = 0.197). Therefore, for subsequent studies of
OMV uptake and intracellular trafficking, the 24 h timepoint of
incubation was used. To confirm the intracellular fluorescence
was attributable to Bt OMVs and not free dye, OMV–Caco-
2 co-cultures were stained with an in-house generated rabbit
anti-Bt OmpA (BT_3852) antisera. DiO OMVs co-localized with
OmpA immune-labeled OMVs, confirming the DiO signal was
specifically associated with Bt OMVs (Supplementary Figure
S1A). Over the time course of the imaging study, Caco-2 cell
viability was unaltered (Supplementary Figure S1B).
Intestinal Epithelial Cells Internalize Bt
OMVs Primarily via Dynamin-Dependent
Endocytosis
The route of bacterial OMV entry by host cells can occur
via several endocytosis pathways, often with multiple pathways
being utilized concurrently (Bielaszewska et al., 2013, 2017;
Olofsson et al., 2014; Kunsmann et al., 2015; Canas et al., 2016).
Therefore, to determine the mechanism of Bt OMV uptake by
IECs, chemical inhibitors were used to block specific endocytosis
pathways using published protocols (Bielaszewska et al., 2013;
Kunsmann et al., 2015). DiO-labeled Bt OMVs were incubated
with Caco-2 monolayers for 24 h prior to trypan blue quenching
and quantification of internalized Bt OMVs by fluorescence
microscopy (Figure 2A). All inhibitors reduced Bt OMV uptake
compared to non-treated control with dynamin-dependent
Dynasore and macropinocytosis inhibitor amiloride significantly
reducing OMV uptake (by 78.1 and 63.42%, respectively). By
comparison, caveolin-mediated inhibitor nystatin (42.32%) and
macropinocytosis F-actin inhibitor cytochalasin D (47.85%)
had only a moderate effect, with clathrin-mediated inhibitor
FIGURE 2 | Dynamin-dependent endocytosis is the main route by which Bt
OMVs are acquired by intestinal epithelial cells. (A) Caco-2 monolayers were
incubated with the endocytosis inhibitors Dynasore, cytochalasin D,
chlorpromazine, nystatin, or amiloride for 1 h prior to the addition of
DiO-OMVs which were subsequently visualized by fluorescence microscopy.
The images shown are representative of those obtained from two independent
experiments. Scale bars = 20 µm. (B) Internalized DiO-OMVs were quantified
using sum fluorescent pixel intensity of each field of view using a macro written
in Image J/FIJI v1.52p. The arbitrary fluorescence units were normalized to
PBS control samples and the mean of each group expressed as average
fluorescence intensity (AU). The data are depicted as the mean of each group
expressed as % of control. The box plots depict mean ± SEM of ≥10 images
and the whiskers min–max values. *p < 0.05, **p < 0.01, ***p < 0.001.
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chlorpromazine (21.11%) having the lowest reduction in
OMV uptake (Figure 2B). These results indicate that uptake
of Bt OMVs occurs predominantly via dynamin-dependent
endocytosis or macropinocytosis with caveolin- and clathrin-
mediated routes of endocytosis also being used but to
a lesser degree.
Intracellular Trafficking of Bt OMVs
As internalized Bt OMVs consistently localized to an intracellular
compartment, we sought to identify the pathway(s) of Bt OMV
trafficking within IECs. To visualize OMV association with
host–cell organelles, DiO-labeled Bt OMVs were incubated with
Caco-2 monolayers or murine caecal- or SI-derived organoid
monolayers for 24 h and assessed by immunofluorescence
microscopy. Organoid cell monolayers were used to reflect the
heterogeneous populations of absorptive and secretory cell types
within the intestinal epithelium and to provide a comparison
with the widely used Caco-2 model. Both caecal and SI-
derived IECs form polarized monolayers within 16 h with apical
microvilli and TJ that comprised the major cell types of the
caecal- and SI epithelium in vivo as determined using antibodies
specific for stem cells, goblet cells, and enteroendocrine cells
(Supplementary Figures S2A–C). Co-localization of Bt OMVs
with host cellular organelles was investigated using the ER
marker PDI, the Golgi apparatus marker 58k, the mitochondrial
marker Tomm20, and the nuclear envelope marker Lamin-B1.
In Caco-2 cells, co-localization (denoted by yellow coloration in
merged image panels of Figure 3) was observed between DiO-
OMVs and the Golgi apparatus (r = 0.599), ER (r = 0.573),
and mitochondria (r = 0.554) (Figure 3A). In caecal organoids
(Figure 3B) co-localization was observed between DiO-OMVs
and Golgi apparatus (r = 0.422), ER (r = 0.417), and mitochondria
(r = 0.516). This suggests that after endocytic uptake at the apical
membrane Bt OMVs traffic to the host Golgi apparatus, ER,
and mitochondria. Although direct DiO-OMV co-localization
with the nuclear envelope was not quantifiable in Caco-
2 (r = 0.003) or caecal organoid monolayers (r = 0.037),
DiO-OMVs were observed in very close proximity with the
nucleus at a distance of between 0.00 and 11.23 µm with
a median distance of 0.819 µm for Caco-2 and between
0.00 and 7.782 µm with a median distance of 0.800 µm for
caecal organoids.
The peri-nuclear accumulation of DiO-positive host vesicles
suggested some OMVs may be sequestered by the host endo-
lysosomal pathway. To identify peri-nuclear vesicles, DiO-
labeled OMVs were incubated with Caco-2 monolayers and
caecal organoid monolayers for 24 h and OMV co-localization
with early endosomes (Rab5+) and lysosomes (LAMP1+ and
LysoID+) investigated (denoted by yellow coloration in merged
image panels of Figure 4). A small population of peri-nuclear
OMVs was shown to co-localize with Rab5+ early-endosomes
in Caco-2 cells (r = 0.371) but not caecal organoid monolayers
(r = 0.166) (Figures 4A,B). Peri-nuclear OMVs were shown to
co-localize with LAMP1/LysoID in Caco-2 cells (r = 0.325 and
r = 0.727 respectively) and with LAMP1 in caecal monolayers
(r = 0.581) (Figures 4A,B), suggesting the peri-nuclear vesicles
containing OMVs are late endosomes or lysosomes. Additionally,
since LysoID detects only organelles with an acidic pH, Bt
OMV uptake did not inhibit endo-lysosomal acidification. Clear
association between Bt OMVs and large DiO-positive host-
derived peri-nuclear vesicles was seen in both caecal and SI
organoid monolayers (Figure 4B and data not shown). This
co-localization of OMVs with the peri-nuclear membrane was
confirmed using high-resolution confocal microscopy, in which
DiO-positive OMVs were shown to be in intimate association
with the nucleus in both Caco-2 and caecal organoid monolayers
(Figures 5A,B). Interestingly, the vesicles presented as frequent,
small puncta (0.2–2.1 µm) in Caco-2 monolayers but as
larger host-associated vesicular compartments (0.2–10.7 µm) in
organoid monolayers (Figure 5C). Taken together these results
FIGURE 3 | Intracellular trafficking of Bt OMVs. (A) Caco-2 monolayers and (B) caecal organoid epithelial monolayers were incubated with DiO-OMVs for 24 h after
which samples were stained with antibodies to visualize the ER (PDI), Golgi network (58K), mitochondria (Tomm20), nuclear membrane (Lamin B1), and the nucleus
(Hoechst 33342). Stained cells were imaged by fluorescence microscopy. The main panels represent merged images from three separate channels that are
individually shown in the side panels. Images are representative of more than three independent experiments. Scale bars = 20 µm.
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FIGURE 4 | Endo-lysosomal trafficking of Bt OMVs. (A) Caco-2 monolayers and (B) caecal organoid epithelial monolayers were treated with DiO-OMVs for 24 h,
fixed and stained with antibodies to visualize early endosomes (Rab5), lysosomes (LAMP1 and LysoID), and the nucleus (Hoechst 33342). The main panels depict
merged images with the side panels showing the individual channels. Images are representative of more than three independent experiments. Scale bars = 20 µm.
indicate that Bt OMVs traffic to the host Golgi apparatus and
ER as well as the nucleus via the endo-lysosomal pathway where
they ultimately accumulate in lysosomal vesicles, presumably for
membrane fusion and release of their cargo.
Intracellular Trafficking of Bt OMVs Is
Autophagy Independent
To establish if OMV trafficking to lysosomes via the endo-
lysosomal pathway is autophagy dependent, an IEC specific,
Atg16l1-deficient mouse model (Atg16l11IEC) was used as
previously described (Jones et al., 2019). The Atg16l1 protein
is a key component of the canonical autophagy pathway and
alongside proteins such as LC3 is required for formation
of autophagosomes. Consequently, Atg16l11IEC mice show
reduced autophagy (Jones et al., 2019). Using SI organoid
monolayers generated from wild-type and Atg16l11IEC mice
the localization of DiO-labeled Bt OMVs to peri-nuclear
host-associated vesicles was comparable in both WT and
Atg16l11IEC organoid monolayers (p = 0.074) (Figure 5D)
excluding any role of autophagy as a cellular process in Bt OMV
intraepithelial trafficking.
Bt OMV Transmigration of the Intestinal
Epithelium
In addition to cellular uptake, OMVs can transmigrate across the
host intestinal epithelium and reach the lamina propria to access
underlying immune cells, the vasculature, and systemic tissues
(Stentz et al., 2018). Caco-2 monolayers were used to determine
if Bt OMVs alter the integrity of the IEC barrier using a cell
culture insert system to measure TEER and translocation of 3–
5 kDa FITC-labeled dextran. In comparison with PBS control,
a significant reduction in TEER was observed within 2 h of
OMV administration which was restored by 24 h (Figure 6A).
In contrast, there was no evidence of FITC–dextran translocation
in response to Bt OMV exposure (Figure 6B) and no loss
or redistribution of the TJ proteins ZO-1 and occludin were
observed Supplementary Figure S4), suggesting Bt OMVs can
modulate certain aspects of the intestinal epithelial barrier.
To investigate this further, fluorescence and confocal imaging
was used to visualize Bt OMV interaction with cellular junctions
and their transmigration across epithelial cell monolayers. After
24 h exposure, Bt DiO-OMVs were seen to localize to lateral
cellular membranes of murine SI organoid monolayers, forming
a distinct chicken-wire like pattern of OMV puncta (Figure 6C).
Confocal imaging of caecal organoid monolayers revealed that
DiO-OMVs were found between cells in a basolateral location
(Figure 6D). Collectively this data suggest Bt OMVs transiently
modulate the host TJ barrier in order to transmigrate across the
intestinal epithelium via the paracellular pathway.
In vivo Biodistribution of Bt OMVs
Following Oral Administration
Following our observation that Bt OMVs transmigrate across
the intestinal epithelium, we sought to determine if after oral
administration Bt OMVs could reach systemic tissues. Using an
in vivo model adapted from those previously described (Park
et al., 2010, 2018; Jang et al., 2015; Wiklander et al., 2015; Kim
et al., 2017), far-red fluorescent DiD-labeled Bt OMVs were orally
administered to mice for 8 h prior to organ excision and imaging
using a Bruker in vivo Xtreme imaging system. This time-point
of tissue collection was optimal to observe the early stages of Bt
OMV biodistribution to tissues via the blood stream. Radiant
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FIGURE 5 | Localization of Bt OMVs to a peri-nuclear membrane. (A) Caco-2 cell monolayers and (B) caecal organoid epithelial monolayers were incubated with
DiO-OMVs for 24 h and stained with phalloidin to visualize the apical membrane and the nuclear stain Hoechst 33342 prior to imaging by confocal microscopy. The
main panels depict merged XY images with the side panels showing XZ and XY orthogonal views. Arrow heads indicate peri-nuclear localization of OMVs. Images
are representative of more than three independent experiments. Scale bars = 20 µm. (C) Quantification of the host peri-nuclear vesicle size was performed using the
straight-line selection tool in Image J/FIJI v1.52p. The box plots depict mean ± SEM and the whiskers min–max values from more than three independent
experiments with more than 200 vesicles quantified per group. (D) Primary SI epithelial organoid monolayers were generated from wild-type control (Left) or
autophagy-deficient (Atg16l11 IEC) mice (Right) and incubated with DiO-OMVs as above and analyzed by fluorescence microscopy. The main panels depict merged
images with the side panels showing the individual channels. Images are representative of more than three independent experiments. Scale bars = 20 µm.
****p < 0.0001.
efficiency of each organ was normalized to PBS control. An
increase in far-red fluorescence was observed in various organs
of DiD-OMV treated mice compared to PBS control (background
autofluorescence) (Figure 7A). The highest signal was detected in
the GI-tract and in particular the SI (51.35%), stomach (11.71%),
caecum (19.70%), and colon (10.14%). Lower intensity signals
were evident in systemic tissues including the liver (9.99%),
lungs (1.04%), and heart (0.63%) (Figure 7B). When the far-
red fluorescence of each organ was analyzed separately to the
tissues of the GI-tract, only the liver exhibited a significant
increase in DiD fluorescence (Figure 7C). As a whole, our
in vivo biodistribution data suggest that Bt OMVs can translocate
through the host GI-tract to reach various systemic tissues with
the greatest accumulation in the liver.
DISCUSSION
Bacterial OMVs normally produced by Gram-negative bacteria
are increasingly being recognized as a secretory inter- and
intra-kingdom communication system (Jan, 2017; Cecil
et al., 2019). However, many features of this mechanism
remain to be defined (Margolis and Sadovsky, 2019). Due
to their nano-size and biophysical properties, OMVs have
the potential to cross the sterile mucous layer that coats
the intestinal epithelium to gain access to host cells and in
particular, boundary epithelial cells. However, their nano-size
also proves a challenge in identifying their specific routes
of uptake by and trafficking within host cells. Here we have
exploited lipophilic dyes that are highly fluorescent upon
incorporation into the OMV membrane bilayer (Parker
et al., 2010; Bielaszewska et al., 2013; Mulcahy et al., 2014;
Kunsmann et al., 2015) to visualize Bt OMVs and track their
uptake and intracellular localization in cultured IECs of the
caecum and small and large intestine, and their subsequent
biodistribution in vivo.
Using high-resolution live-imaging we demonstrate that
Bt OMV cellular uptake occurs rapidly (within 15 min) in
IEC monolayers, which is consistent with previous studies
(Furuta et al., 2009b; Parker et al., 2010; Olofsson et al., 2014;
Kunsmann et al., 2015). In contrast to studies using pathogen-
derived OMVs that are generally toxic (Furuta et al., 2009a;
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FIGURE 6 | Bt OMV transmigrate the host GI-tract. (A) Non-labeled Bt OMVs were administered to the apical compartment of tissue culture inserts containing a
confluent, polarized monolayer of Caco-2 cells. Transepithelial electrical resistance (TEER) was measured at regular intervals post-treatment. The graph depicts
mean ± SEM values from two independent experiments with five technical replicates. (B) To assess cell permeability, 3–5 kDa FITC-labeled dextran (1 µg/ml) was
added to the apical compartment during OMV administration and FITC fluorescence measured in both the apical and basal compartments at 24 h
post-administration of OMVs. The bar graph depicts mean ± SEM values from two independent experiments with five technical replicates. (C) Small intestinal (SI)
organoid epithelial monolayers were incubated with DiO-OMVs for 24 h and stained with antibodies to visualize lateral cell membranes (E-cadherin) and with a
nuclear stain (Hoechst 33342) prior to fluorescence microscopy. The main panel shows merged images with the side panels depicting the separate channels. Arrow
heads indicate lateral cell membrane localization of OMVs. (D) Caecal organoid epithelial monolayers were incubated with DiO-OMVs for 24 h and stained with
phalloidin to visualize apical cell membranes and the nuclear stain Hoechst 33342 prior to analysis by confocal microscopy. The main panels show merged XY
images and the side panels show XZ and XY orthogonal views. Arrow heads indicate paracellular localization of OMVs. Images are representative of more than three
independent experiments. Scale bars = 20 µm. *p < 0.05, ****p <0.0001.
Bielaszewska et al., 2017), Bt OMVs have no discernable
adverse effect on epithelial viability. Uptake of Bt OMVs
by IECs occurs via all four main pathways of endocytosis:
actin-driven macropinocytosis, clathrin-mediated endocytosis,
caveolin-mediated endocytosis, or non-caveolin- and non-
clathrin-mediated endocytosis (O’Donoghue and Krachler, 2016)
with dynamin-dependent endocytosis and macropinocytosis
being the most prominent. The utilization of different pathways
by Bt OMVs for their uptake may reflect their size heterogeneity
(20 to >400 nm) and the size selectivity of each route of
endocytosis with macropinocytosis for instance allowing uptake
of OMVs < 1 µm whereas clathrin- and caveolin-mediated
endocytosis enables uptake of smaller OMVs < 120 nm
(O’Donoghue and Krachler, 2016). This interpretation is
supported by the recent finding that the size of Helicobacter
pylori OMVs determined their mechanism of endocytosis
(Turner et al., 2018).
Most endocytic routes of Bt OMV uptake culminate in
lysosomes located in a peri-nuclear region (Furuta et al., 2009b;
Bielaszewska et al., 2013; Figure 8), which we found does
not require autophagosome formation and therefore autophagy
(Tooze et al., 2014). We have observed that intracellular Bt OMVs
persist within lysosmes for >72 h (data not shown) suggesting
they may resist intracellular degradation for prolonged periods
of time after their acquisition. As the caveolin-dependent
endocytosis pathway bypasses lysosomes it is likely that OMVs
are transported via the caveolar network to the host ER/Golgi
apparatus (Figure 8) thereby escaping lysosomal degradation
(Kiss and Botos, 2009; Figure 8). An important caveat to this
interpretation is that endocytosis pathways used by transformed,
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FIGURE 7 | In vivo biodistribution of Bt OMVs following oral administration. (A) Mice were orally administered with DiD-OMVs (OMVDiD, 2 × 1010/mouse) or PBS
and individual organs (Right) excised at 8 h post-administration for imaging using a Bruker in vivo Xtreme imaging system. The images shown are representative of
those obtained from four mice per group. (B,C) The graphs depict the proportion (B) or absolute (C) amount of the fluorescence signal from the OMVDiD inoculum
or PBS control administered to each animal that was subsequently detected in each organ. The box plots depict mean ± SEM and the whiskers min–max values.
***p < 0.001.
proliferating cells in culture such as Caco-2 may differ to those in
primary cells such as the intestinal epithelium where quiescent,
senescent, and terminally differentiated cells are present (Hinze
and Boucrot, 2018). Our use of primary epithelial cells in the form
of organoid monolayers which reflect the cellular heterogeneity
of the intestinal epithelium in vivo represents one approach to
overcoming the limitations of using immortalized cell lines.
Our findings reveal that commensal Bt OMVs are internalized
by primary murine organoid monolayers derived from the SI
and caecum which contain proliferating and non-proliferating
cell types such as goblet cells and enteroendocrine cells (Sato
et al., 2009; Zachos et al., 2016). Some differences in the fate
of Bt OMVs between organoid and Caco-2 cell culture systems
were evident. Larger peri-nuclear host-associated vesicles, of up
to 10.7 µm, were observed in primary organoid monolayers
compared to smaller peri-nuclear host-associated vesicle puncta
(average 0.8 µm) in Caco-2 cells. This may reflect differences
in lysosomal storage, degradation, and exocytosis of Bt OMVs
between immortalized and tumor-derived Caco-2 cells and
primary IECs. Further studies are required to determine how
these differences relate to the fate of internalized OMVs and their
potential delivery to the nucleus.
Under normal healthy conditions, the selectively permeable
TJ barrier of the intestinal epithelium allows the flux of ionic
solutes (leak pathway) as well as larger non-charged molecules
(pore pathway) (Shen et al., 2011). As paracellularly located
OMVs were only observed in primary caecal organoid cultures
and not Caco-2 monolayers, this may reflect different TJ pore
capacities of the different cell types. TJs in primary cells are
“leakier” than in Caco-2 monolayers (Van Itallie et al., 2008;
Turner et al., 2014) as reflected by electrical resistance (TEER)
and permeability (FITC–dextran) measurements demonstrating
that only the leak pathway appears to be modulated by Bt
OMVs. It was therefore not surprising that OMVs could not be
detected in basal supernatants of Caco-2 monolayers (data not
shown). The more permeable TJ barrier of primary compared to
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FIGURE 8 | A schematic representation of the uptake and fate of Bt OMVs in the GI-tract. The diagram depicts the predicted pathways of Bt OMV uptake and
transmigration of the host GI-tract epithelium to reach the systemic circulation and systemic organs such as the liver. (1) Transcellular transmigration.
(2) Caveolin-mediated endocytosis and subsequent inclusion in caveolar vesicles (CV) and trafficking to the endoplasmic reticulum (ER) and Golgi network (GN).
(3) Endo-lysosomal trafficking via early endosomes (EE), late endosomes (LE), and lysosomes (L) to co-localize to the nucleus (N) and the peri-nuclear membrane.
(4) Paracellular transmigration and passage through tight junctions (TJ). (5) Translocation to lamina propria and interaction with immune cells such as dendritic cells
(DCs). (6) Distribution to the hepatic circulation and portal vein (PV) and subsequent delivery to the liver (7). (8) Distribution to lymphatic vessels and/or the systemic
circulation and dissemination to more distant organs such as the heart and lungs (9). The solid arrows identify confirmed pathways with dashed arrows representing
predicted pathways.
immortalized IECs enables the paracellular transmigration of a
small population of Bt OMVs (Figure 8), allowing them to access
underlying cells and the vasculature (Figure 8). A disrupted TJ
barrier as a result of injury or inflammation could lead to a greater
proportion of Bt OMVs being translocated across the GI-tract to
host tissues. Further investigations are required to determine if Bt
OMV cellular uptake and fate changes in disease states.
Based on our in vitro findings and the fact that bacterial
EVs have previously been detected in human serum (Tulkens
et al., 2018), we speculated that orally administered Bt OMVs
can cross the murine GI-tract and be delivered to other
tissues systemically. We have shown that within 8 h of oral
administration small numbers of labeled OMVs are evident in
several organs and most notably the liver. In contrast to the
parenteral administration of OMVs described in previous studies
(Jang et al., 2015; Wiklander et al., 2015; Kim et al., 2017;
Park et al., 2018), oral administration of Bt OMVs facilitates
their interaction with the host GI-tract that is analogous to
that of endogenously produced OMVs (Sonnenburg et al.,
2005; Porter et al., 2017). The finding that the vast majority
of Bt OMVs remain in the lumen of the GI-tract suggests
that the general fate of OMVs generated in vivo is excretion.
Our biodistribution study does however indicate that a small
population of luminal Bt OMVs can enter the circulatory or
lymphatic systems via the GI-tract. As the liver was the primary
site for OMV biodistribution in our study, it is likely that
OMVs transmigrating through the intestinal epithelium enter
the hepatobiliary system (Figure 8). The finding of Bt OMVs
in the heart and lungs also suggests that some OMVs can also
enter the blood stream. As OMVs are proteoliposomes, they
likely move through the lymphatics prior to entering the blood
circulation (Figure 8). Our results suggest therefore that Bt
OMVs interact with and can cross several host cellular barriers
including the intestinal epithelial barrier and the lymphatic- and
vascular-endothelium (Figure 8).
While our combined in vitro and in vivo approach to studying
OMV-mediated interactions between members of the intestinal
microbiota with their host has verified the delivery of intact Bt
OMVs into and across the intestinal epithelium, identifying the
pathways of Bt OMV transport within the body and the sites of
delivery of their cargo remains a challenge.
CONCLUSION
We have shown that OMVs from the prominent gut commensal
bacterium Bt have the potential to act as a long-distance
microbiota–host communication system. Bt OMVs interact with
cells of the GI-tract via several endocytosis pathways, ultimately
localizing to endo-lysosomal vesicles in close proximity to the
peri-nuclear membrane. Additionally, a proportion of Bt OMVs
transmigrate through epithelial cells via a paracellular route and
in vivo can cross the IEC barrier to reach systemic organs.
Understanding in more detail the biodistribution pathways
and ultimate targets of OMVs is key to elucidating their
benefit to host health.
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